HomeTRUALT › Filing
🔔 Get instant alerts when TRUALT files quarterly results on BSE Start free trial →

Please find attached the Intimation

Filed: 04 Aug 2026, 13:44 IST Exchange: BSE Category: Financial Results — Earnings Call Transcript
AI summary - Q1 FY27 ethanol revenue approx INR630 crores on 8.5 crore litres sales - EBITDA margin improved to 23.5%, PAT margin 9.5%, with 60% capacity utilization - CBG segment revenue INR11 crores, PAT margin 40-45%, 78% utilization - Capex underway: INR700 crores for CBG plants, INR2000 crores planned for SAF by FY29 - Ethanol volume guidance for FY27 at 44 crore litres with potential upside - SAF expected price INR180-190/litre with 24-25% margin; revenues from FY29 - Dual feed plants improve margins by 6% vs sugar-based feedstock - Working capital from IPO supports raw material procurement at favorable prices - Multiple analyst queries on feedstock mix, capex, and margin sustainability addressed
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TRUALT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TRUALT to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on TruAlt Bioenergy Limited

Important. The summary above is generated automatically from TruAlt Bioenergy Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.